1. Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes
   Damien Massalou et al, 2017, The American Journal of Surgery CrossRef
2. Clinical significance of the KRAS G13D mutation in anastomotic recurrence of colorectal cancer
   Keigo Matsunaga et al, 2023, Oncology Letters CrossRef
3. An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer
   Narendranath Epperla et al, 2016, Journal of Gastrointestinal Cancer CrossRef
4. Prognostic Impact of Deficient DNA Mismatch Repair and KRAS and BRAF V600E Mutations in Patients with Lymph-Node-Positive Colon Cancer
   Aziz Zaanan et al, 2014, Current Colorectal Cancer Reports CrossRef
5. SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer
   Liliana Terrin et al, 2017, Oncotarget CrossRef
6. ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
   Jun Hou et al, 2022, Frontiers in Pharmacology CrossRef
7. EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma
   Vanessa Szablewski et al, 2013, International Journal of Molecular Sciences CrossRef
8. Mutations of key driver genes in colorectal cancer progression and metastasis
   Dongdong Huang et al, 2018, Cancer and Metastasis Reviews CrossRef
9. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review)
   Ha Nguyen et al, 2018, Oncology Letters CrossRef
10. Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosis
    Sujeong Park et al, 2018, Animal Cells and Systems CrossRef
11. Correlation between RAS Test Results and Prognosis of Metastatic Colorectal Cancer Patients: a Report from Western Iran
    Mehrdad Payandeh et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
12. Frequency and Clinical Impact of KRAS Mutations in Patients with Colorectal Cancer from the Middle East
    null Jamal Zekri et al, 2016, Journal of Analytical Oncology CrossRef
13. GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer
    Kai Xu et al, 2016, Oncology Reports CrossRef
14. Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
    Amanda K. Arrington et al, 2012, International Journal of Molecular Sciences CrossRef
15. Histology and its prognostic effect on KRAS‑mutated colorectal carcinomas in Korea
    Hye Lee et al, 2020, Oncology Letters CrossRef
16. Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients
    Leila Hamzehzadeh et al, 2018, Current Problems in Cancer CrossRef
17. Effect of KRAS and BRAF mutations in metastatic colorectal cancer patients: A systematic review and meta-analysis based on tumor sidedness and KRAS subtypes
    Khadijeh Saravani et al, 2021, Human Antibodies CrossRef
18. The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka
    Nirmala Dushyanthi Sirisena et al, 2017, BMC Research Notes CrossRef
19. KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
    A I Phipps et al, 2013, British Journal of Cancer CrossRef
20. The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis
    Hae Su Kim et al, 2016, BMC Cancer CrossRef